Magnetics Business & Technology - September/October 2022 - 8

FEATURE ARTICLE
Fortis Life Sciences a New Force in Magnetic Particles with nanoComposix
With its acquisition of nanoComposix, fast-growing Fortis Life
Sciences is emerging as a new force in the field of magnetic
particle development and manufacturing. The venture capitalbacked
firm acquired nanomaterials company nanoComposix
and three others in its first year of operations, while signaling that
more deals are on the way.
The nanoComposix acquisition brings aboard an extensive
portfolio of magnetic and other nano-particle products as well as
the capability to serve as a contract manufacturer of particles for
other life sciences companies and for industrial applications. Focused
on solutions for assay development and diagnostics, since
2004 nanoComposix has built a comprehensive nanomaterials
portfolio for drug delivery, diagnostics and imaging, as well as
industrial applications. The combination of nanoComposix with
other Fortis portfolio companies is expected to lead to a powerful
synergy within the life science reagent space.
nanoComposix
founder Steve
Oldenburg
Recently, nanoComposix focused its efforts
on the life sciences market and has
seen rapid adoption of its nanoparticles in
a wider variety of diagnostic and therapeutic
applications. " Combining our unique
nanoparticle products with accelerated development
services has led to an explosion
of interest in our nanoparticles and their
applications, " commented founder Steve
Oldenburg when the transaction closed in
2021. " Fortis is the perfect growth partner
for us to continue to provide our customers
with world-class support in this dynamic market. "
8 Magnetics Business & Technology * September/October 2022
" We're incredibly fortunate to have
these companies integrated into the
Fortis organization, " said Brian Kim,
chief executive offficer of Fortis,
headquartered in Waltham, Massachusetts.
Established in August 2020 by a
team of life science industry veterans
in collaboration with global growth
equity investor Summit Partners, Fortis
specializes in acquiring founder-led
biotech company and plans to continue
acquiring and investing in more partner
companies.
Brian Kim, CEO of Fortis
Life Sciences
Headquartered in San Diego, California, nanoComposix has
extensive experience with the synthesis and development of
complex nanomaterials and coatings, and has produced a broad
assortment of well-characterized, precisely-tuned magnetic
nanoparticles as standard products and on a custom basis.
Its magnetic-plasmonic gold
nanoshells, for example,
typically consist of a dielectric
core, a thin layer of silica and a
uniformly thin outer layer of gold
with unique and tunable optical
properties. This material can
be used for medical diagnostic
assays and photothermal
therapies. The company has
fabricated magnetic-responsive
Microscope image of 300 nm
gold nanoshells
www.MagneticsMag.com
http://www.MagneticsMag.com
Magnetics Business & Technology - September/October 2022

Table of Contents for the Digital Edition of Magnetics Business & Technology - September/October 2022
